Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | GLO1 | Q04760 | 4/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | ADK | P55263 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23076209 | 0.90 | L3MBTL1 (0.40) | L3MBTL1GLO1HSP90AA1ALDH1A1KDR | |
| SCHEMBL23076198 | 0.78 | HPGD (0.33) | L3MBTL1GLO1HSP90AA1ALDH1A1TSHR | |
| SCHEMBL23076202 | 0.77 | PLA2G2A (0.39) | L3MBTL1ALDH1A1ADORA3 | |
| SCHEMBL23075955 | 0.71 | RET (0.43) | ALDH1A1KDR | |
| SCHEMBL23076022 | 0.69 | KDM4E (0.57) | L3MBTL1ALDH1A1TSHRPOLB | |
| SCHEMBL23075992 | 0.68 | RET (0.46) | ALDH1A1KDR | |
| SCHEMBL23075995 | 0.68 | POLB (0.36) | L3MBTL1ADKTSHRADORA2AADORA1 | |
| SCHEMBL24663212 | 0.67 | HSD17B10 (0.54) | HSP90AA1ALDH1A1POLB | |
| SCHEMBL21390299 | 0.65 | MEN1 (0.59) | L3MBTL1ALDH1A1ADORA2AADORA1POLB | |
| SCHEMBL14426033 | 0.65 | MEN1 (0.59) | L3MBTL1ALDH1A1ADORA2AADORA1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220310932-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-09-29 | — | — | US | disclosed |
| WO-2021043703-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220310932-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | OR10J3, EPCAM, L1CAM | L3MBTL1 1415/4885GLO1 1153/4885HSP90AA1 4490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.